3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Recurrent Anaplastic Large Cell Lymphoma: new trials by email Literature Review of Recurrent Anaplastic Large Cell Lymphoma trials Research Report on Recurrent Anaplastic Large Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Laboratory Biomarker Analysis, Nivolumab - Blastic Plasmacytoid Dendritic Cell Neoplasm, Hepatosplenic T-Cell Lymphoma | Phase 2 | Terminated | Mayo Clinic | 12 | 2017-05-17 | 2020-04-21 |
| Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL Onalespib - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 25 | 2016-04-04 | 2022-09-13 |
| Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 46 | 2010-05-19 | 2023-01-23 |
Lymphoma, Large-Cell, Anaplastic (3) · Lymphoma, Mantle-Cell (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Burkitt Lymphoma (1) · Enteropathy-Associated T-Cell Lymphoma (1) · HTLV-I Infections (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Leukemia, Biphenotypic, Acute (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Hematologic Diseases (2) · Infections (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphoma, B-Cell (2) · Lymphoma, T-Cell (2)
(2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone (1) · Cyclophosphamide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Mycophenolic Acid (1) · Nivolumab (1) · Peripheral Blood Stem Cell Transplantation (1) · Tacrolimus (1) · Whole-Body Irradiation (1) · fludarabine phosphate (1)
Fred Hutchinson Cancer Center (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1)
United States (3)
Caron A Jacobson (1) · Rachel B. Salit (1) · Stephen Ansell (1)
P30CA015083 (1), UM1CA186690 (1), UM1CA186709 (1)